Cardinal Partners
Signal active
Investment Firm
Overview
Cardinal Partners is a venture capital partnership focused exclusively on healthcare investing.
Highlights
Founded
1996
Industry
Venture Capital
Employees
1-10
Investment
59
Lead Investment
10
Exits
19
Stages
Early Stage Venture, Late Stage Venture, Private Equity
Investor Type
Micro Vc
Location
United States, North America
Contact Information
Social
Profile Resume
Cardinal Partners, established in 1996 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Private Equity investments across Biotechnology, Health Care, Pharmaceutical, Financial Services, Venture Capital, Advice, Finance, Medical, Non Profit, Impact Investing. The organization boasts a portfolio of 59 investments, with an average round size of $26.9M and 19 successful exits. Their recent investments include Sirtris Pharmaceuticals, Polaris Partners, Skyline Ventures, TVM Capital, Wellcome Trust. The highest investment round they participated in was $134.1B. Among their most notable exits are Sirtris Pharmaceuticals and Polaris Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Cardinal Partners has made 59 investments. Their most recent investment was on Apr 30, 2019, when Vividion Therapeutics raised $82.0M.
Cardinal Partners has made 15 diversity investments. Their most recent diversity investment was on Sep 24, 2015, when lifeIMAGE raised $5.1M.
investments
59
Diversity investments
15
Lead investments
10
Number of exits
19
Investments
59
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Feb 02, 2017 | Vividion Therapeutics | Biotechnology | 50.0M |
| Sep 27, 2017 | - | - | 6.1M |
| Jun 18, 2018 | Cureatr | Information Technology | 3.0M |
| Apr 30, 2019 | Vividion Therapeutics | Biotechnology | 82.0M |
Exits
19
Funding Timeline
Funding rounds
59
Investors
0
Funds
4
Funding Rounds
59
Cardinal Partners has raised 59 rounds. Their latest funding was raised on Apr 30, 2019 from a Series B - Vividion Therapeutics round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Feb 02, 2017 | Series A - Vividion Therapeutics | - | 50.0M | - |
| Sep 27, 2017 | Series A - Prealize Health | - | 6.1M | - |
| Jun 18, 2018 | Venture Round - Cureatr | - | 3.0M | - |
| Apr 30, 2019 | Series B - Vividion Therapeutics | - | 82.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.